当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析 - 资产负债表

派林生物

(000403)

  

流通市值:169.52亿  总市值:171.26亿
流通股本:9.41亿   总股本:9.50亿

资产负债表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
流动资产:
  货币资金559,086,605.74666,259,948.781,321,124,262.61754,186,603.94
  交易性金融资产477,097,058.24752,031,267.79282,702,336.481,000,209,682.43
  应收票据及应收账款630,115,456.37508,906,181.4668,989,985.91579,108,848.4
  其中:应收票据53,598,738.3624,616,664.5237,768,154.867,932,995.11
        应收账款576,516,718.01484,289,516.88631,221,831.05571,175,853.29
  应收款项融资18,784,578.9129,980,323.2941,696,512.8113,203,838.86
  预付款项26,158,271.7351,499,291.6123,011,355.2446,060,757.91
  其他应收款合计6,557,976.017,393,205.36,155,410.758,372,736.88
  其中:应收利息1,331,506.851,827,991.831,627,397.261,479,452.05
  存货1,600,890,769.751,436,677,512.891,233,248,553.271,139,194,714.69
  其他流动资产2,004,808.9416,902,103.022,020,116.681,990,316.21
  流动资产合计3,320,695,525.693,469,649,834.083,578,948,533.753,542,327,499.32
非流动资产:
  长期应收款600,000,000600,000,000600,000,000600,000,000
  其他非流动金融资产6,000,0006,000,0006,000,000-
  投资性房地产290,514.35297,634.31304,754.27311,874.23
  固定资产1,749,643,575.21,501,906,582.141,462,342,887.31,373,956,195.97
  在建工程284,157,362.98516,422,273.4513,359,045.14463,311,557.62
  使用权资产17,559,236.0221,899,793.9223,452,859.6125,006,305.98
  无形资产191,850,228.48195,982,845.01200,333,103.32203,906,755.23
  开发支出149,183,307.11131,852,297.21109,769,448.8292,103,597.55
  商誉2,614,611,614.122,614,611,614.122,614,611,614.122,614,611,614.12
  长期待摊费用46,782,017.8243,356,819.2643,781,684.629,443,653.11
  递延所得税资产29,336,175.3330,023,008.0229,425,352.7841,043,900.39
  其他非流动资产71,186,565.5964,698,137.3863,940,081.5387,193,349.45
  非流动资产合计5,760,600,5975,727,051,004.775,667,320,831.515,510,888,803.65
  资产总计9,081,296,122.699,196,700,838.859,246,269,365.269,053,216,302.97
流动负债:
  短期借款396,933,638.24297,001,776.42310,489,207.3265,698,040.33
  应付票据及应付账款137,928,789.39185,200,789.24224,256,183.28178,491,158.71
  其中:应付票据15,839,722.5615,839,722.563,931,864.18-
        应付账款122,089,066.83169,361,066.68220,324,319.1178,491,158.71
  合同负债3,895,339.86,734,628.716,357,121.19,684,977.64
  应付职工薪酬33,896,334.623,782,054.9873,521,208.0231,492,784.63
  应交税费40,011,245.9638,917,393.9948,616,877.1354,976,186.36
  其他应付款合计230,977,137.46220,027,480.51256,664,579.36288,087,246.09
        应付股利2,156,191.371,472,493.321,472,493.321,007,905.37
  一年内到期的非流动负债41,200,255.5645,518,786.2422,119,759.3537,219,818.8
  其他流动负债19,194,761.4510,683,869.2414,946,816.745,806,402.28
  流动负债合计904,037,502.46827,866,779.33956,971,752.28871,456,614.84
非流动负债:
  长期借款217,886,435.89294,842,822.5303,221,491.31271,227,337.53
  租赁负债12,966,267.9217,196,758.8518,604,949.2822,034,052.35
  长期应付款9,000,0009,000,0009,000,0009,000,000
  预计负债647,107---
  递延收益25,995,961.9726,419,638.826,843,315.6333,479,292.75
  递延所得税负债13,222,124.2114,933,363.6514,125,221.4121,192,151.77
  非流动负债合计279,717,896.99362,392,583.8371,794,977.63356,932,834.4
  负债合计1,183,755,399.451,190,259,363.131,328,766,729.911,228,389,449.24
所有者权益(或股东权益):
  实收资本(或股本)950,397,386731,074,913731,074,913733,043,291
  资本公积4,538,892,789.164,758,215,262.164,758,215,262.164,796,355,404.07
  减:库存股---40,108,519.91
  其他综合收益51,734.5653,564.3654,271.6740,943.34
  盈余公积161,574,403.37159,123,167.84159,123,167.84133,435,422.24
  未分配利润2,253,648,584.82,365,272,352.532,276,183,136.882,208,944,306.43
  归属于母公司股东权益合计7,904,564,897.898,013,739,259.897,924,650,751.557,831,710,847.17
  少数股东权益-7,024,174.65-7,297,784.17-7,148,116.2-6,883,993.44
  股东权益合计7,897,540,723.248,006,441,475.727,917,502,635.357,824,826,853.73
  负债和股东权益合计9,081,296,122.699,196,700,838.859,246,269,365.269,053,216,302.97
公告日期2025-08-222025-04-242025-04-242024-10-28
审计意见(境内)标准无保留意见
TOP↑